New tool aims to help melanoma patients with autoimmune conditions navigate treatment choices

NCT ID NCT04751396

Recruiting now Knowledge-focused Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Nov 10, 2025 · Last updated May 22, 2026 · Updated 28 times

Summary

This study is testing a new educational tool designed for people with melanoma who also have an autoimmune disease (like rheumatoid arthritis or Crohn's disease). The tool helps patients understand immune checkpoint inhibitor drugs and their possible side effects. Researchers will ask 125 patients and their doctors about how easy the tool is to use and whether it helps with treatment decisions. The goal is to improve the tool so it better supports patients in making informed choices.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

M D Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

Contact Phone: •••-•••-••••

Contact

Conditions

Explore the condition pages connected to this study.

ANKYLOSING SPONDYLITIS AUTOIMMUNE DISEASE CROHN DISEASE ENTEROPATHIC ARTHRITIS ENTEROPATHIC SPONDYLITIS INFLAMMATORY BOWEL DISEASE MELANOMA PSORIASIS PSORIATIC ARTHRITIS REACTIVE ARTHRITIS REACTIVE ARTHRITIS RHEUMATOID ARTHRITIS SYSTEMIC LUPUS ERYTHEMATOSUS SYSTEMIC LUPUS ERYTHEMATOSUS ULCERATIVE COLITIS ULCERATIVE COLITIS